These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7514373)

  • 41. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens.
    Daugé V; Steimes P; Derrien M; Beau N; Roques BP; Féger J
    Pharmacol Biochem Behav; 1989 Sep; 34(1):157-63. PubMed ID: 2626446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular pathways mediating tachykinin-evoked secretomotor responses in guinea pig ileum.
    MacNaughton W; Moore B; Vanner S
    Am J Physiol; 1997 Nov; 273(5):G1127-34. PubMed ID: 9374711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin.
    Altar CA; Boyar WC
    Brain Res; 1989 Apr; 483(2):321-6. PubMed ID: 2706523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101.
    Dauge V; Corringer PJ; Roques BP
    Pharmacol Biochem Behav; 1995 Feb; 50(2):133-9. PubMed ID: 7740050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
    Corp ES; McQuade J; Moran TH; Smith GP
    Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholecystokinin-A receptor mediation of food intake in cats.
    Bado A; Durieux C; Moizo L; Roques BP; Lewin MJ
    Am J Physiol; 1991 Apr; 260(4 Pt 2):R693-7. PubMed ID: 2012242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.
    Johnson NJ; Rodgers RJ
    Psychopharmacology (Berl); 1996 Apr; 124(4):355-64. PubMed ID: 8739551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
    Gronier B; Debonnel G
    Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional role of brain CCK receptors.
    Woodruff GN; Hill DR; Boden P; Pinnock R; Singh L; Hughes J
    Neuropeptides; 1991 Jul; 19 Suppl():45-56. PubMed ID: 1881532
    [No Abstract]   [Full Text] [Related]  

  • 52. Characterization of cholecystokinin receptors in canine intestinal circular muscle.
    Mao YK; Wang YF; Daniel EE
    Peptides; 1995; 16(6):1025-9. PubMed ID: 8532583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells.
    Meyer G; Beinborn M; Sewing KF
    Pharmacology; 1996 Jul; 53(1):48-59. PubMed ID: 8875601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antagonistic effect of CCK-8 on morphine-inhibited electrical and contractile activities of rat jejunum in vitro.
    Xu MY; Yang DX; Wang SZ; Jin HB; Zou XH; Yang XP; Han JS
    Sheng Li Xue Bao; 1998 Aug; 50(4):469-73. PubMed ID: 11324560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain.
    Boden PR; Woodruff GN; Pinnock RD
    Br J Pharmacol; 1991 Mar; 102(3):635-8. PubMed ID: 1364831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protection induced by cholecystokinin-8 (CCK-8) in ethanol-induced gastric lesions is mediated via vagal capsaicin-sensitive fibres and CCKA receptors.
    Evangelista S; Maggi CA
    Br J Pharmacol; 1991 Jan; 102(1):119-22. PubMed ID: 2043917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of cholecystokinin activity by albumin.
    Huang SC; Talkad VD; Fortune KP; Jonnalagadda S; Severi C; Delle Fave G; Gardner JD
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10312-6. PubMed ID: 7479774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of cholecystokinin on gastric motility in humans.
    Beglinger C
    Ann N Y Acad Sci; 1994 Mar; 713():219-25. PubMed ID: 8185162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCKB receptor activation protects CA1 neurons from ischemia-induced dysfunction in stroke-prone spontaneously hypertensive rats hippocampal slices.
    Yasui M; Kawasaki K
    Neurosci Lett; 1995 May; 191(1-2):99-102. PubMed ID: 7659302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.